#ACC24 Late-Breaker RCT confirms Impella CP® improves survival by 12.7%, compared to the control arm without Impella, in heart attack with shock. Congratulations to Jacob Møller, MD, and all the independent investigators on today's publication in @NEJM.
https://t.co/l9Xr2oFbTU
Presented today at #ACC24:
In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: https://t.co/3625asvzu8
Grateful to @CircAHA for publishing our @nih_nhlbi funded 'bed-to-bench' research identifying novel mechanisms (and therapeutic targets) by which #ECMO regulates myocardial biology and #mitochondrial integrity that are independent of #hemodynamic load.
https://t.co/3JwbwPU3bt
Great to spend quality time at #A-CURE @AHAMeetings with my hard-working, fun, disruptive, innovative, and always-up-for-anything team! Grateful, honored, and humbled to work with you as we advance the field of #unloading and cardiac remodeling @TuftsMedicalCtr@TuftsMCResearch
@BhaveShreyas@NavinKapur4 Thank you so much Shreyas! @BhaveShreyas I owe this success to our entire team of excellent lab mates. Thanks for always inspiring and encouraging! Cheers to our whole team!🎉
@KayEverettMDPhD@TuftsMedicalCtr Thank you so much Kay! It’s Awesome to have lab mates like you #KayEverettMDPhD. Because of the constant support, encouragement,help and critical feedback from all the lab mates makes our lab an exciting and fun place to work at. Thanks for always being Awesome ❤️